Susan E. Barrowcliffe
Overview
Susan E. Barrowcliffe received $2M in total compensation, including $303K in salary, at Aimmune Therapeutics in 2018.
Source: SEC filing on April 10, 2019.
Related executives
We found nine more executives who work or worked at Aimmune Therapeutics.
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Andrew Oxtoby
Aimmune Therapeutics
Chief Commercial Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Douglas Sheehy
Aimmune Therapeutics
General Counsel
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
Jeffrey Knapp
Aimmune Therapeutics
Chief Operating Officer
Warren DeSouza
Aimmune Therapeutics